A two-branch, daily-rebalanced strategy: a small, RSI-driven hedged lane (LAB Rats) and a larger momentum lane that picks one top stock from a list (Tribromoethanol). Uses levered ETFs for amplified moves and a volatility hedge, with two moving-average momentum screens guiding the stock pick. High risk and high potential reward.

Two main lanes operate daily: - LAB Rats (about a tenth of the portfolio): a small, conditional lane that uses momentum signals on broad market indices to decide whether to tilt toward volatility (UVXY), triple-levered tech (TECL/TQQQ), or biotech bets (LABU/LABD). Signals come from overbought/oversold indicators (explained simply as whether recent price behavior is extremely strong or weak) and relative strength comparisons among proxies like QQQ, SPY, IEF, and IWM. The nested rules mean that if the market looks overheated, the system tends to hedge with UVXY; if tech momentum looks depressed yet likely to rebound, it may tilt to a tech levered ETF; if conditions favor biotech momentum relative to bonds and breadth, it may tilt into LABU or LABD. The LAB Rats branch also contains a reference to bonds and breadth to keep risk in check. The exact numeric weights are staged (a small primary weight and a larger nested weight) to keep this lane smaller than the main one. - Tribromoethanol (about 80% of the portfolio): a stock-picking lane that searches a fixed list of major tickers (e.g., NVIDIA, AMD, KLA Corp, Super Micro, Eli Lilly, Novo Nordisk) and selects the single best performer based on momentum over two windows (roughly 10 days and 21 days). Each window ranks the candidates by how much their price has risen on average recently, and the top candidate from that window is chosen for investment. In effect, this lane is a disciplined, single-stock momentum bet focused on high-profile growth plays. Both lanes rebalance every trading day, so positions can change day to day. The leverage used in several assets (UVXY, TECL, TQQQ, LABU/LABD) means returns can swing violently and costs/decay of leveraged products can erode performance over time. The strategy relies on simple momentum signals rather than complex fundamentals and is designed for a high-risk, potentially high-reward profile.

A disciplined two-branch, rule-based strategy that diversifies beyond the S&P 500 with momentum stock picks and hedges. Daily rebalanced, it targets positive risk-adjusted returns in volatile markets via selective leverage and a volatility hedge.